21.94USD+1.29%Mkt Cap: 494.46M $P/E: 56.261d ago
NRC Health provides analytics and insights to measure and improve patient and employee experience for healthcare organizations in the United States. The company offers market experience solutions, a subscription-based se…
Industry Peers
Health Information Services$32.06BUSDP/E 35.0
$13.38BUSDP/E 88.5
$9.62BUSD
$8.27BUSDP/E 37.0
$6.65BUSD
$5.65BUSD
$4.44BUSDP/E 34.6
$3.43BUSDP/E 160.1
$2.24BUSD
$2.14BUSDP/E 106.8
$1.71BUSD
$1.41BUSD
$1.17BUSD
$1.13BUSD
$1.06BUSDP/E 52.0
$874.42MUSDP/E Infinity
$845.49MUSDP/E 43.2
$672.72MUSDP/E 68.1
$637.77MUSD
$581.77MUSDP/E 27.4
$584.81MUSD
$552.27MUSDP/E 13.1
$524.39MUSD
$516.62MUSD
$460.71MUSDP/E 25.8
$446.52MUSDP/E 25.4
$393.58MUSDP/E 90.5
$368.70MUSDP/E 45.6
$321.33MUSD
$230.81MUSDP/E 14.1
$224.12MUSDP/E 18.2
$217.63MUSD
$182.96MUSD
$156.35MUSDP/E 39.4
$168.48MUSD
$148.67MUSDP/E 29.6
$123.72MUSDP/E Infinity
$124.79MUSDP/E 18.5
$113.48MUSDP/E 25.4
$99.01MUSDP/E 17.9
$86.66MUSD
$65.63MUSDP/E 11.3
$62.29MUSDP/E 22.6
$57.34MUSD
$47.87MUSDP/E 57.6
$49.50MUSD
$40.55MUSDP/E 38.7
$39.14MUSD
$31.93MUSD
$26.93MUSDP/E 26.0
$22.91MUSDP/E 54.8
$20.17MUSD
$18.43MUSD
$12.99MUSD
$13.69MUSD
$12.35MUSD
$11.72MUSD
$9.78MUSDP/E 15.1
$6.67MUSD
$6.50MUSD
$5.63MUSD
$4.88MUSD
$3.78MUSDP/E Infinity
$3.83MUSDP/E 0.0
$3.40MUSD
$2.98MUSD
$2.70MUSD
$2.16MUSDP/E Infinity
$693.4KUSD
$548.9KUSDP/E 0.0
$282.6KUSD
—
—
—
CRY
GraniteShares YieldBOOST CRCL ETF—
EYES
Corgi Data & Surveillance ETF—P/E 30.8
Indicators:|
Key Statistics
Company
Market Cap494.46M $
Enterprise Value569.94M $
Revenue (TTM)138.64M $
Gross Profit85.02M $
Net Income (TTM)11.60M $
Revenue/Share6.276 USD
Last Price21.94 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees357
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)56.26
P/E (Forward)20.50
PEG1.32
EV/EBITDA16.47
EV/Revenue4.11
P/S3.57
P/B36.63
EPS (TTM)0.39
EPS (Forward)1.07
52W Range
11.0191% of range23.00
52W High23.00 USD
52W Low11.01 USD
Profitability
Gross Margin61.88%
Oper. Margin16.00%
EBITDA Margin24.96%
Profit Margin8.44%
ROE82.92%
ROA8.60%
Growth
Revenue Growth3.70%
Earnings Growth-44.00%
Cash Flow & Leverage
Operating CF26.45M $
CapEx (TTM)10.71M $
FCF Margin14.23%
FCF Yield3.99%
Net Debt75.48M $
Net Debt/EBITDA2.18
Balance Sheet
Debt/Equity5.65
Current Ratio0.52
Quick Ratio0.36
Book Value/Sh0.5990 USD
Cash/Share0.1130 USD
Dividends
Fwd Div Rate0.6000 USD
Trail. Div Rate0.5600 USD
Div. Yield2.77%
5Y Avg Yield2.06%
Payout Ratio143.59%
Ex-Div DateJun 26, 2026
Pay DateJul 10, 2026
Analyst Consensus
Rating—
Target (Mean)23.00 USD
Upside (mean)+4.8%
Target Range23.00 USD – 23.00 USD
# Analysts1
Ownership
Shares Out.22.54M
Float12.23M
Insiders48.87%
Institutions49.62%
Short Interest
Short Ratio2.7d
Short % Float16.60%
Short % Out.2.08%
Shares Short468.68K
Short (prev mo.)466.58K
Technical
SMA 5019.86 (+10.5%)
SMA 20017.07 (+28.6%)
Beta0.38
S&P 52W Chg20.25%
Avg Vol (30d)138.14K
Avg Vol (10d)85.21K
Technical Indicators
RSI (14)59.9
MACD0.7192
MACD Signal0.7532
MACD Hist.-0.0340
BB Upper23.93 USD
BB Middle21.02 USD
BB Lower18.10 USD
BB Width27.72%
ATR (14)1.033 USD
Vol Ratio (20d)0.55x